We are thrilled to announce that our client, an IT expert in software development of applied artificial intelligence (AI), machine learning (ML), and Internet of Things (IoT), has successfully obtained USCIS approval for his EB-1A petition.
Our Client:
Our client created AI-driven solutions to tackle counterfeit drugs and enhance pharmaceutical cybersecurity to ensure patient safety and drug authenticity. His innovations revolutionized advanced manufacturing and supply chain processes. As a Senior Solution Manager for a global IT enterprise, our client has been instrumental in analyzing, architecting, deploying, integrating, and supporting advanced systems for diverse industries across the globe. Today, he is a key member of an elite group of experts tasked with solving highly complex enterprise resource planning (ERP) challenges for major corporations across the United States.
The Winning Case:
Our legal team’s strategy focused on our client’s leading and critical roles. Evidence showed that he received internationally recognized prizes for excellence in his field, commanded a high salary in his field, and was a member of associations in the field that require outstanding achievements. Major media published articles about his accomplishments in his field. When USCIS issued a Request for Evidence (RFE), the agency agreed that our client had published scholarly articles and had served as a judge of the work of others in his field.
In our RFE response, we highlighted existing evidence and furnished ample new evidence. For example, we highlighted our client's role in leading critical projects during the COVID-19 global pandemic. His work in supply chain management for the life sciences industry significantly enhanced health security and economic resilience in the U.S. Through letters of reference (LOR) from leading experts in the field, we demonstrated our client’s client’s extraordinary ability in several important areas that directly benefit the U.S. and its interests:
Counterfeit Drug Protection: The client’s development of advanced AI and IoT solutions has greatly enhanced pharmaceutical cybersecurity, effectively safeguarding against counterfeit drugs and ensuring patient safety and drug authenticity.
Supply Chain Optimization: The client’s work in predictive demand and automated replenishment has significantly improved manufacturing efficiency, playing a crucial role in optimizing supply chains within both the life sciences and industrial manufacturing sectors.
ERP Innovation: The client’s leadership in integrating AI and ML into ERP systems has led to enhanced data analytics and security, driving innovation in enterprise resource planning.
Our client continues to lead innovation in IT solutioning, making a significant impact on industries and communities across the U.S. In 2023 alone our client secured more than $65 million in contract signing for his employer’s consulting division.
Outcome: Win! After an RFE, USCIS approved our client's EB-1A petition within a week of our RFE response. Our client continues to lead innovation in IT solutioning, and is making a significant impact on industries and communities throughout the U.S. Congratulations!
Comments